Treatments for MS: Gilenya ® (fingolimod) There are currently several disease-modifying therapies approved for people with MS in

First Page		Document Content
Date: 2015-03-01 21:43:46 Anatomy Fingolimod Sphingosine-1-phosphate MS Australia Remyelination Therapies under investigation for multiple sclerosis Treatment of multiple sclerosis Multiple sclerosis Immunology Immune system		Treatments for MS: Gilenya ® (fingolimod) There are currently several disease-modifying therapies approved for people with MS in Add to Reading List Source URL: www.mssociety.org.au Download Document from Source Website File Size: 131,32 KB Share Document on Facebook

	Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio DocID: 1qn6Z - View Document
	Stellungnahme der AkdÄ zur Nutzenbewertung von Fingolimod (neues Anwendungsgebiet) DocID: 1n48S - View Document
	Rote-Hand-Brief zu Gilenya® (Fingolimod) DocID: 1h06f - View Document
	Biotin (Cerenday) for permanent disability related to multiple sclerosis relapses – add on therapy to current immunomodulators DocID: 1fWCE - View Document
	Bijlage bij email betreffende vergoeding fingolimod juliArtikel uit MenSen nr. 4 Samenvatting aanvullende voorwaarden zoals is overeengekomen op 4 juni 2013 met CVZ, VWS, zorgverzekeraars, MS Vereniging Nederland, DocID: 1ea9n - View Document